Heghine Khachatryan: A Valuable Educational Resource on Inhibitor Development
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders (EAHAD)’s post on LinkedIn, adding:
“An outstanding educational initiative.
As gene therapy continues to transform haemophilia care, a deeper understanding of inhibitor development remains fundamental to ensuring both efficacy and long-term safety.
Thank you for this valuable educational resource.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Missed our latest Gene Therapy online session or want to rewatch it?
The full replay of ‘Inhibitor Development in Gene Therapy for Haemophilia’ is now available on the EAHAD Academy.
And stay tuned for our next Gene Therapy webinar!”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Oct 9, 2026, 07:00Danny Reardon: Closing the Global Awareness Gap on Blood Clots
-
Oct 9, 2026, 00:54Mary Catherine Moffett: Advancing Advocacy Together – Highlights from the Sanofi Bleeding Disorders Summit
-
Oct 9, 2026, 00:46Paris Margaritis: Assays vs Outcomes – Connecting FVIII Expression to Bleeding Phenotype in Hemophilia A
-
Oct 9, 2026, 00:39Rodrigo Arreola Diaz: The Rise of Concizumab for Hemophilia A and B
-
Oct 8, 2026, 23:27Shayan Mohammadmoradi: Happy to Be Back at the Midwest Platelet Conference for Its 20th Meeting
-
Oct 8, 2026, 23:18Lorena Arranz: Honoured to Contribute to the 6th Global MPN Symposium
-
Oct 8, 2026, 23:06Denis Oduor: Serving Citizens and Saving Lives Through Blood Donation During National Customer Service Week 2026
-
Oct 8, 2026, 22:51Jan Hartmann: Speaking on Global Trends in Plasma Collection at the 50th Meeting of the Japanese Society of Blood Services
-
Oct 8, 2026, 22:49Akshat Jain: Proud to Announce the Publication of Advances in Sickle Cell Disease